219 related articles for article (PubMed ID: 23256816)
21. The design and delivery of a thermally responsive peptide to inhibit S100B-mediated neurodegeneration.
Hearst SM; Walker LR; Shao Q; Lopez M; Raucher D; Vig PJ
Neuroscience; 2011 Dec; 197():369-80. PubMed ID: 21958864
[TBL] [Abstract][Full Text] [Related]
22. Theoretical study on binding of S100B protein.
Gieldon A; Mori M; Del Conte R
J Mol Model; 2007 Nov; 13(11):1123-31. PubMed ID: 17713798
[TBL] [Abstract][Full Text] [Related]
23. The Ca(2+)-dependent interaction of S100B(beta beta) with a peptide derived from p53.
Rustandi RR; Drohat AC; Baldisseri DM; Wilder PT; Weber DJ
Biochemistry; 1998 Feb; 37(7):1951-60. PubMed ID: 9485322
[TBL] [Abstract][Full Text] [Related]
24. Calcium-dependent interaction of S100B with the C-terminal domain of the tumor suppressor p53.
Delphin C; Ronjat M; Deloulme JC; Garin G; Debussche L; Higashimoto Y; Sakaguchi K; Baudier J
J Biol Chem; 1999 Apr; 274(15):10539-44. PubMed ID: 10187847
[TBL] [Abstract][Full Text] [Related]
25. CRISPR/dCas9-KRAB-Mediated Suppression of
Roy Choudhury S; Heflin B; Taylor E; Koss B; Avaritt NL; Tackett AJ
Cells; 2023 Feb; 12(5):. PubMed ID: 36899866
[TBL] [Abstract][Full Text] [Related]
26. Calcium and S100B regulation of p53-dependent cell growth arrest and apoptosis.
Scotto C; Deloulme JC; Rousseau D; Chambaz E; Baudier J
Mol Cell Biol; 1998 Jul; 18(7):4272-81. PubMed ID: 9632811
[TBL] [Abstract][Full Text] [Related]
27. In vitro screening and structural characterization of inhibitors of the S100B-p53 interaction.
Wilder PT; Charpentier TH; Liriano MA; Gianni K; Varney KM; Pozharski E; Coop A; Toth EA; Mackerell AD; Weber DJ
Int J High Throughput Screen; 2010 Jul; 2010(1):109-126. PubMed ID: 21132089
[TBL] [Abstract][Full Text] [Related]
28. S100B-mediated inhibition of the phosphorylation of GFAP is prevented by TRTK-12.
Frizzo JK; Tramontina F; Bortoli E; Gottfried C; Leal RB; Lengyel I; Donato R; Dunkley PR; Gonçalves CA
Neurochem Res; 2004 Apr; 29(4):735-40. PubMed ID: 15098935
[TBL] [Abstract][Full Text] [Related]
29. S100B and lactate dehydrogenase as response and progression markers during treatment with vemurafenib in patients with advanced melanoma.
Abusaif S; Jradi Z; Held L; Pflugfelder A; Weide B; Meier F; Garbe C; Eigentler TK
Melanoma Res; 2013 Oct; 23(5):396-401. PubMed ID: 23907232
[TBL] [Abstract][Full Text] [Related]
30. Computational screening and design of S100B ligand to block S100B-p53 interaction.
Whitlow JL; Varughese JF; Zhou Z; Bartolotti LJ; Li Y
J Mol Graph Model; 2009; 27(8):969-77. PubMed ID: 19324580
[TBL] [Abstract][Full Text] [Related]
31. Proteins of the S100 family regulate the oligomerization of p53 tumor suppressor.
Fernandez-Fernandez MR; Veprintsev DB; Fersht AR
Proc Natl Acad Sci U S A; 2005 Mar; 102(13):4735-40. PubMed ID: 15781852
[TBL] [Abstract][Full Text] [Related]
32. Ions binding to S100 proteins. I. Calcium- and zinc-binding properties of bovine brain S100 alpha alpha, S100a (alpha beta), and S100b (beta beta) protein: Zn2+ regulates Ca2+ binding on S100b protein.
Baudier J; Glasser N; Gerard D
J Biol Chem; 1986 Jun; 261(18):8192-203. PubMed ID: 3722149
[TBL] [Abstract][Full Text] [Related]
33. Fragmenting the S100B-p53 interaction: combined virtual/biophysical screening approaches to identify ligands.
Agamennone M; Cesari L; Lalli D; Turlizzi E; Del Conte R; Turano P; Mangani S; Padova A
ChemMedChem; 2010 Mar; 5(3):428-35. PubMed ID: 20077460
[TBL] [Abstract][Full Text] [Related]
34. A novel mode of target recognition suggested by the 2.0 A structure of holo S100B from bovine brain.
Matsumura H; Shiba T; Inoue T; Harada S; Kai Y
Structure; 1998 Feb; 6(2):233-41. PubMed ID: 9519413
[TBL] [Abstract][Full Text] [Related]
35. Solution NMR structure of S100B bound to the high-affinity target peptide TRTK-12.
Inman KG; Yang R; Rustandi RR; Miller KE; Baldisseri DM; Weber DJ
J Mol Biol; 2002 Dec; 324(5):1003-14. PubMed ID: 12470955
[TBL] [Abstract][Full Text] [Related]
36. The calcium-dependent interaction between S100B and the mitochondrial AAA ATPase ATAD3A and the role of this complex in the cytoplasmic processing of ATAD3A.
Gilquin B; Cannon BR; Hubstenberger A; Moulouel B; Falk E; Merle N; Assard N; Kieffer S; Rousseau D; Wilder PT; Weber DJ; Baudier J
Mol Cell Biol; 2010 Jun; 30(11):2724-36. PubMed ID: 20351179
[TBL] [Abstract][Full Text] [Related]
37. The C-terminus and linker region of S100B exert dual control on protein-protein interactions with TRTK-12.
McClintock KA; Van Eldik LJ; Shaw GS
Biochemistry; 2002 Apr; 41(17):5421-8. PubMed ID: 11969402
[TBL] [Abstract][Full Text] [Related]
38. Inhibition of p53 transcriptional activity by the S100B calcium-binding protein.
Lin J; Blake M; Tang C; Zimmer D; Rustandi RR; Weber DJ; Carrier F
J Biol Chem; 2001 Sep; 276(37):35037-41. PubMed ID: 11454863
[TBL] [Abstract][Full Text] [Related]
39. Accuracy of the determination of S100B protein expression in malignant melanoma using polyclonal or monoclonal antibodies.
Tímár J; Udvarhelyi N; Bánfalvi T; Gilde K; Orosz Z
Histopathology; 2004 Feb; 44(2):180-4. PubMed ID: 14764062
[TBL] [Abstract][Full Text] [Related]
40. The prognostic value of serum S100B in patients with cutaneous melanoma: a meta-analysis.
Mocellin S; Zavagno G; Nitti D
Int J Cancer; 2008 Nov; 123(10):2370-6. PubMed ID: 18752249
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
